Revisiting En Bloc Resection Versus Piecemeal Resection for the Treatment of Giant Cell Tumor of the Spine
- Abstract
- Objective: Surgery for spinal giant cell tumors (GCTs) is challenging because these tumors often exhibit a poor clinical course owing to their locally aggressive features. This study aimed to investigate the prognostic factors of GCT recurrence in the spine by focusing on surgical factors.
Methods: We retrospectively reviewed patients who underwent surgery for spinal GCTs between January 2005 and December 2016. Using the Kaplan-Meier method, surgical variables were evaluated for disease-free survival (DFS). Since tumor violation may occur at the pedicle during en bloc resection of the spine, it was further analyzed as a separate variable. Multivariate Cox proportional hazard regression analysis was performed for other clinical and radiographic variables. A total of 28 patients (male:female = 8:20) were included. The mean follow-up period was 90.5 months (range, 15-184 months).
Results: Among the 28 patients, gross total resection (GTR) was the most important factor for DFS (P = 0.001). Any form of tumor violation was also correlated with DFS (P = 0.049); however, use of en bloc resection technique did not show a significant DFS gain compared to piecemeal resection (P = 0.218). In the patient group that achieved GTR, the mode of resection was not a significant factor for DFS (P = 0.959). In the multivariate analysis, the extent of resection was the only significant variable that affected DFS (P = 0.016).
Conclusions: Conflicting results on tumor violation from univariate and multivariate analyses suggest that GTR without tumor violation should be the treatment goal for spinal GCTs. However, when tumor violation is unavoidable, it would be important to prioritize GTR over adhering to en bloc resection.
- Issued Date
- 2023
Sungjoon Lee
Sun-Ho Lee
Joon Ho Yoon
Chi Heon Kim
Jin Hoon Park
Sang Hyub Lee
Chang-Hyun Lee
Seung-Jae Hyun
Sang Ryong Jeon
Ki-Jeong Kim
Eun-Sang Kim
Chun Kee Chung
- Type
- Article
- Keyword
- Denosumab; Giant cell tumors; Prognosis; Spine; Surgery; Survival analysis
- DOI
- 10.1016/j.wneu.2023.07.016
- URI
- https://oak.ulsan.ac.kr/handle/2021.oak/16184
- Publisher
- World Neurosurgery
- Language
- 한국어
- ISSN
- 1878-8750
- Citation Volume
- 178
- Citation Number
- `
- Citation Start Page
- 165
- Citation End Page
- 173
-
Appears in Collections:
- Medicine > Nursing
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.